Despite the effectiveness of vaccination in preventing severe COVID-19, some individuals remain at risk. The study goal was to determine risk factors for COVID-19 requiring hospital admission. A case-control study was conducted in Porto Alegre, Brazil. Vaccinated adults with confirmed SARS-CoV-2 infection from February 2021 to March 2023 were eligible. Hospitalized patients (cases) and outpatients with non-severe infections (control group) were time-matched in a 1: 1 ratio. Moreover, we followed hospitalized patients (cases) to evaluate factors related to 30-day mortality and/or ventilation support. We included 364 patients: 182 cases and 182 controls. Age > 60 years (odds ratio OR 3. 98 95% confidence intervalCI 2. 23-7. 19), male sex (OR 3. 07 95%CI 1. 78-5. 40), diabetes mellitus (OR 4. 61 95% CI 2. 08-11. 08), cardiovascular disease (OR 4. 07 95%CI 1. 73-10. 64), lung disease (OR 3. 06 95%CI 1. 39-6. 94), obesity (OR 3. 39 95%CI 1. 29-9. 73), and previous infection (OR 0. 19 95%CI 0. 06-0. 51) were independently related to COVID-19 hospital admission. In the arm of hospitalized patients, the number of vaccine doses (OR 0. 53 95%CI 0. 39-0. 73) was a protective factor against 30-day mortality and/or ventilation support, whereas obesity (OR1. 62 95%CI 1. 19-2. 20) was a risk factor. Health policies should consider focusing on these risk populations for targeted interventions, such as additional boosters, early treatment and prophylaxis.
Sorio et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: